急性基底动脉闭塞伴轻中度症状患者机械取栓的结局
本研究采用目标试验模拟方法,比较机械取栓(±静脉溶栓)与单纯静脉溶栓在基底动脉闭塞且基线NIHSS评分<10患者中的疗效。结果显示,取栓组90天mRS 0-2分比例更高(63.9% vs 54.2%,aOR 1.56),且院内死亡率更低(aOR 0.45)。
要点
- 基底动脉闭塞且NIHSS<10患者中,取栓组90天良好功能结局(mRS 0-2)优于单纯溶栓(aOR 1.56)。
- 取栓组院内死亡风险更低(aOR 0.45,95%CI 0.25-0.78)。
- NIHSS 6-9分患者取栓获益大于NIHSS<6分者(交互作用P=0.02)。
核心结论
- 在基底动脉闭塞且NIHSS评分<10的患者中,与单纯静脉溶栓相比,机械取栓(±静脉溶栓)与更好的90天功能结局相关。
- NIHSS评分<6分患者中机械取栓的获益尚需进一步研究确认。
研究设计与样本
- 目标试验模拟研究,数据来自意大利急性卒中血管内治疗登记(取栓±静脉溶栓,发病24小时内)和SITS国际卒中溶栓登记(单纯静脉溶栓,发病9小时内),2011年至2021年。
- 纳入成人基底动脉闭塞、基线NIHSS评分<10、病前mRS 0-2分的患者,共764例(男性477例[62.4%],平均年龄67.88[±13.9]岁)。
- 采用逆概率加权(IPW)校正预设协变量,加权后取栓组710例、静脉溶栓组707例。
主要发现
- 取栓组454例(63.9%)与静脉溶栓组383例(54.2%)达到90天mRS 0-2分(aOR 1.56,95%CI 1.04-2.03)。
- 取栓组90天mRS 0-1分比例更高(aOR 2.01,95%CI 1.37-2.95)。
- 取栓组院内死亡率更低(aOR 0.45,95%CI 0.25-0.78)。
- 亚组分析显示,NIHSS 6-9分患者取栓对90天mRS 0-2分的效应大于NIHSS<6分患者(交互作用P=0.02)。
局限性
- 需进一步研究确认NIHSS评分<6分患者中机械取栓的获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The benefit of mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) with basilar artery occlusion (BAO) and a baseline National Institute of Health Stroke Scale (NIHSS) score <10 is unclear because this subpopulation has been substantially excluded from large clinical trials. The aim of our study was to determine whether MT ± IV thrombolysis (IVT) improves functional outcomes compared with IVT alone in patients with BAO and a NIHSS score <10. METHODS: We emulated a hypothetical trial including adult patients with BAO, a baseline NIHSS score <10, and prestroke modified Rankin scale (mRS) scores 0-2, comparing MT (±IVT) with IVT alone. We acquired data from patients receiving MT (±IVT) within 24 hours of onset from the Italian Registry of Endovascular Treatment in Acute Stroke and data from patients treated only with IVT within 9 hours of symptom onset from the SITS International Stroke Thrombolysis Register, from 2011 until 2021. We used inverse probability weighting (IPW) adjusted for prespecified covariates to weight each individual's contribution to the outcome. The primary outcome was 90-day mRS scores 0-2. Secondary outcomes included 90-day mRS scores 0-1, 90-day mRS scores 4-5, mortality at 90 days, in-hospital death, and symptomatic intracerebral hemorrhage. RESULTS: Among the 764 patients recruited from the 2 databases (477 men [62.4%]; mean age [±SD] 67.88 [±13.9] years), 410 (53.7%) received MT±IVT and 354 (46.3%) only IVT. After applying IPW, our population was composed of 710 MT and 707 IVT patients. Of these, 454 MT-treated (63.9%) and 383 IVT-treated (54.2%) patients had a 90-day mRS score of 0-2 (adjusted odds ratio (aOR) 1.56 [95% CI 1.04-2.03]). MT was also associated with a higher rate of mRS scores 0-1 (aOR 2.01 [95% CI 1.37-2.95]) and a lower rate of in-hospital death (aOR 0.45 [95% CI 0.25-0.78]). Among the subgroups tested, MT had a larger effect on 90-day mRS scores 0-2 for patients with NIHSS scores 6-9 than for patients with a NIHSS score <6 (p for interaction 0.02). DISCUSSION: In a large-scale target trial emulation on patients with stroke from BAO and a NIHSS score <10, MT was associated with better functional outcomes compared with IVT alone. Further research is needed to confirm the benefit of MT in patients with a NIHSS score <6. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that MT ± intravenous thrombolysis is associated with better 90-day functional outcomes in patients with BAO and a NIHSS score < 10 compared with intravenous thrombolysis alone.
引用
- Nicolini E, Pracucci G, Ciacciarelli A, et al. Outcomes of Mechanical Thrombectomy in Patients With Acute Basilar Artery Occlusion With Mild to Moderate Symptoms. Neurology. 2024. PMID: 39571122. doi:10.1212/WNL.0000000000210086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。